Cleared Traditional

K791860 - FERRITIN RIA KIT

K791860 is an FDA 510(k) clearance for FERRITIN RIA KIT, manufactured by Cis Radiopharmaceuticals, Inc.. The device is a Class 2 Immunology device with product code DBF cleared through the Traditional 510(k) pathway after a 78-day FDA review.

K791860 · Cis Radiopharmaceuticals, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1979
Decision
78d
Days
Class 2
Risk

K791860 is an FDA 510(k) clearance for the FERRITIN RIA KIT. Classified as Ferritin, Antigen, Antiserum, Control (product code DBF), Class II - Special Controls.

Submitted by Cis Radiopharmaceuticals, Inc. (Mchenry, US). The FDA issued a Cleared decision on December 6, 1979 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cis Radiopharmaceuticals, Inc. devices

FDA 510(k) Submission Details - K791860

510(k) Number K791860 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 1979
Decision Date December 06, 1979
Days to Decision 78 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
27d faster than avg
Panel avg: 105d · This submission: 78d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DBF Device Classification - Class 2, Special Controls

Product Code DBF Ferritin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBF Ferritin, Antigen, Antiserum, Control

All 76
Devices cleared under the same product code (DBF) and FDA review panel - the closest regulatory comparables to K791860.
FERRITIN RIA KIT
K800299 · Amersham Corp. · Mar 1980
CENTRIA FERRITIN RIA
K792449 · Union Carbide Corp. · Dec 1979
FERRITIN RADIOIMMUNOASSAY
K792442 · Dade, Baxter Travenol Diagnostics, Inc. · Dec 1979
VENTRE/SEP FERRITIN RIA
K790447 · Ventrex Laboratories, Inc. · Apr 1979
IN VITRO FERRITIN RIA TEST
K770702 · Clinical Assays, Inc. · Jun 1977